安杰思(688581.SH)：拟以6500万元对杭安医学进行增资

Group 1 - The core viewpoint of the article is that Anjisi (688581.SH) is making a strategic investment in Hang'an Medical to deepen its high-end diagnostic equipment industry layout, marking a key move in the company's long-term development plan in research and manufacturing [1] - The company plans to invest 65 million yuan of its own funds to increase its stake in Hang'an Medical, which is a minority shareholder of Hang'an Medical's employee equity incentive platform [1] - After the capital increase, Hang'an Medical's registered capital will change from 55 million yuan to 120 million yuan, and the company's ownership in Hang'an Medical will increase from 90.9091% to 95.8333%, maintaining its status as a controlling subsidiary [1]